← Elevance Health, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $4.1b $3.6b $3.9b $4.9b $5.7b $4.9b $7.4b $6.5b $8.3b $9.5b
Other current assets $1.8b $2.2b $2.1b $2.3b $4.1b $4.7b $5.3b $5.8b $4.7b $5.3b
Other receivables $2.5b $2.3b $2.6b $2.6b $2.8b $3.7b $4.3b $5.4b $6.0b $6.3b
Premium receivables — $3.6b $4.5b $5.2b $5.3b $5.7b $7.1b $7.9b $8.0b $10.1b
Restricted Cash and Investments, Current $157.0m $91.2m $222.0m $215.0m $170.0m $173.0m $258.0m $294.0m $409.0m $348.0m
Self-funded receivables — — — $2.6b $2.8b $4.0b $4.7b $4.6b $5.0b $5.2b
Assets, Current $34.3b $36.3b $34.3b $39.0b $45.8b $51.1b $55.6b $60.0b $58.9b $63.0b
Total current assets $34.3b $36.3b $34.3b $39.0b $45.8b $51.1b $55.6b $60.0b $58.9b $63.0b
Property, Plant and Equipment, Net $2.0b $2.2b $2.7b $3.1b $3.5b $3.9b $4.3b $4.4b $4.7b $4.7b
Goodwill $17.6b $19.2b $20.5b $20.5b $21.7b $24.2b $24.4b $25.3b $28.3b $28.3b
Intangible Assets, Net (Excluding Goodwill) $8.0b $8.4b $9.0b $8.7b $9.4b $10.6b $10.3b $10.3b $12.1b $11.2b
Other intangible assets $8.0b $8.4b $9.0b $8.7b $9.4b $10.6b $10.3b $10.3b $12.1b $11.2b
Operating Lease, Right-of-Use Asset — — — — — — $604.0m $584.0m $567.0m $452.0m
Other Assets, Noncurrent $467.9m $565.3m $758.0m $1.4b $1.4b $1.7b $1.7b $2.0b $2.1b $2.3b
Other noncurrent assets $467.9m $565.3m $758.0m $1.4b $1.4b $1.7b $1.7b $2.0b $2.1b $2.3b
Additional Financial Items
Assets held for sale — — — — — — — $0 $490.0m $0
Equity securities $31.4m $32.8m $33.0m $30.0m $1.6b $1.9b $953.0m $229.0m $1.2b $740.0m
Fixed maturity securities (amortized cost of $25,773 and $25,879; allowance for credit losses of $21 and $6) $524.4m $560.8m $487.0m $505.0m $562.0m $26.3b $26.0b $29.6b $1.0b $1.1b
Liabilities held for sale — — — — — — — $0 $153.0m $0
Other current liabilities $3.6b $3.3b $3.2b $3.7b $6.1b $7.8b $9.7b $9.9b $10.0b $10.3b
Other invested assets $2.2b $3.3b $3.7b $4.2b $4.3b $5.2b $5.7b $6.1b $9.7b $10.8b
Other policyholder liabilities $2.2b $3.0b $2.6b $3.0b $4.6b $5.5b $5.9b $5.6b $4.2b $3.6b
Reserves for future policy benefits $666.1m $647.3m $706.0m $674.0m $794.0m $802.0m $737.0m $778.0m $190.0m $145.0m
Short-term borrowings $440.0m $1.3b $1.1b $700.0m $0 $275.0m $265.0m $225.0m $365.0m $150.0m
Unearned income $971.9m $860.3m $902.0m $1.0b $1.3b $1.2b $1.1b $1.4b $1.5b $1.5b
AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax $361.2m $533.7m ($159.0m) $521.0m $949.0m — — — — —
Total equity — — — — $33.2b $36.1b $36.4b $39.4b $41.4b $44.0b
Total shareholders’ equity $25.1b $26.5b $28.5b $31.7b $33.2b $36.1b $36.3b $39.3b $41.3b $43.9b
Assets $65.1b $70.5b $71.6b $77.5b $86.6b $97.5b $102.8b $108.9b $116.9b $121.5b
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable and accrued expenses $4.0b $5.0b $5.0b $4.2b $5.5b $5.0b $5.6b $6.9b $6.9b $7.3b
Long-term Debt, Current Maturities $928.4m $1.3b $849.0m $1.6b $700.0m $1.6b $1.5b $1.6b $1.6b $1.1b
Long-term Debt, Excluding Current Maturities $14.4b $17.4b $17.2b $17.8b $19.3b $21.2b $22.3b $23.2b $29.2b $30.8b
Long-term debt, less current portion $14.4b $17.4b $17.2b $17.8b $19.3b $21.2b $22.3b $23.2b $29.2b $30.8b
Medical claims payable $7.9b $8.0b $7.5b $8.8b $11.4b $13.5b $15.6b $16.1b $15.7b $17.1b
Operating Lease, Liability, Current — — — — — — $181.0m $164.0m $153.0m $131.0m
Operating Lease, Liability, Noncurrent — — — — — — $751.0m $685.0m $658.0m $529.0m
Liabilities, Current $21.3b $23.4b $22.0b $23.6b $29.5b $34.9b $39.7b $41.8b $40.6b $41.0b
Total current liabilities $21.3b $23.4b $22.0b $23.6b $29.5b $34.9b $39.7b $41.8b $40.6b $41.0b
Deferred Income Tax Liabilities, Net $2.8b $1.7b $2.0b $2.2b $2.0b $2.8b $2.0b $2.0b $2.1b $2.1b
Other Liabilities, Noncurrent $883.8m $925.1m $1.2b $1.4b $1.8b $1.7b $1.6b $1.7b $3.3b $3.4b
Other noncurrent liabilities $883.8m $925.1m $1.2b $1.4b $1.8b $1.7b $1.6b $1.7b $3.3b $3.4b
Deferred Tax Liabilities, Net $2.8b $1.7b $2.0b $2.2b $2.0b $2.7b $1.9b $1.7b $1.9b $1.8b
Liabilities $40.0b $44.0b $43.0b $45.7b $53.4b $61.3b $66.4b $69.5b $75.5b $77.5b
Stockholders’ equity:
Accumulated Other Comprehensive Income (Loss), Net of Tax ($267.9m) ($101.5m) ($986.0m) ($296.0m) $150.0m ($178.0m) ($2.5b) ($1.3b) ($1.1b) ($451.0m)
Accumulated other comprehensive loss ($267.9m) ($101.5m) ($986.0m) ($296.0m) $150.0m ($178.0m) ($2.5b) ($1.3b) ($1.1b) ($451.0m)
Additional Paid in Capital $8.8b $8.5b $9.5b $9.4b $9.2b $9.1b $9.1b $8.9b $8.9b $8.9b
Common Stock, Value, Issued $2.6m $2.6m $3.0m $3.0m $3.0m $2.0m $2.0m $2.0m $2.0m $2.0m
Common stock, par value $0.01, shares authorized - 900,000,000; shares issued and outstanding - 220,723,898 and 227,479,695 2.6m 2.6m 3.0m 3.0m 3.0m 2.0m 2.0m 2.0m 2.0m 2.0m
Preferred Stock, Value, Issued $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Preferred stock, without par value, shares authorized - 100,000,000; shares issued and outstanding - none 0 0 0 0 0 0 0 0 0 0
Retained Earnings (Accumulated Deficit) $16.6b $18.1b $20.0b $22.6b $23.8b $27.1b $29.7b $31.7b $33.5b $35.4b
Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax $52.9m $19.1m $18.0m $4.0m ($7.0m) — — — — —
Stockholders' Equity Attributable to Parent $25.1b $26.5b $28.5b $31.7b $33.2b $36.1b $36.3b $39.3b $41.3b $43.9b
Noncontrolling interests — — — — $0 $68.0m $87.0m $99.0m $111.0m $144.0m
Stockholders' Equity Attributable to Noncontrolling Interest — — — — — $68.0m $87.0m $99.0m $111.0m $144.0m
Liabilities and Equity $65.1b $70.5b $71.6b $77.5b $86.6b $97.5b $102.8b $108.9b $116.9b $121.5b

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.